BioSpace News Archive

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, announced today that the Company will release its third quarter 2019 financial results on Thursday, November 14, 2019, prior to the U.S. financial markets open

Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today reported financial results and provided a business update for the third quarter ended September 30, 2019.

MaxisIT today announced that it has GONE LIVE with MaxisIT’s Integrated Clinical Development Platform together with Tobacco Harm Reduction pioneer, Philip Morris International (PMI). PMI has awarded MaxisIT a multi-year SaaS agreement to use MaxisIT’s Clinical Data Repository, Clinical data management Hub, Statistical computing Environment and Analytics solutions for their global clinical assessment program.

Stereotaxis (NYSE American: STXS) and ADAS 3D Medical SL today announced the first patients have been successfully treated with the integration of ADAS 3D’s advanced preoperative substrate mapping and Stereotaxis’ Robotic Magnetic Navigation technologies.

Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy and other rare disorders, will report its third quarter of 2019 financial results and corporate update shortly after the NASDAQ market close on Thursday, November 7.

Nationwide sale of rhinestone phone ring and stand raising funds and awareness of living kidney donation ahead of holiday season

Survey reveals scale of epilepsy’s impact on the lives of patients and caregivers - including fear of having a seizure or losing independence

Nektar Therapeutics (NASDAQ:NKTR) announced today that it will webcast an analyst and investor conference call with a melanoma specialist and company management on Sunday, November 10, 2019 at 9:00 a.m. EST in Washington, D.C. during the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting.

With open enrollment for 2020 health plans under the Affordable Care Act beginning, eHealth, Inc. has released an analysis of federal marketplace plan data showing that lower 2020 premiums may be canceled out by higher out-of-pocket costs for many consumers..

CVD Equipment Corporation (NASDAQ: CVV), a leading provider of chemical vapor deposition systems, announced today that it will release its 2019 third quarter results after markets close on Tuesday, November 12, 2019.